No, "Prestique" (Neck-Strengthening Program) Does Not Help with Migraine Prevention
Based on the highest quality evidence, neck-strengthening exercises, including programs like "Prestique," are not effective for reducing migraine frequency or intensity and should not be recommended as a primary preventive strategy for hemiplegic migraine. 1
Evidence Against Neck-Strengthening for Migraine Prevention
The most rigorous study examining this question—a randomized controlled trial of craniocervical muscle-strengthening exercises (CMSE)—found no significant differences in headache frequency or intensity after 8 weeks of treatment or at 3-month follow-up compared to sham ultrasound 1. While this study showed some improvements in muscle function metrics (reduced EMG activity), these physiological changes did not translate into clinically meaningful reductions in migraine burden.
A 2026 systematic review confirms this finding, concluding that current evidence remains insufficient to establish clear benefit for migraine prevention outcomes from cervical strengthening and stabilization exercises 2. The meta-analysis showed:
- No statistically significant effect on headache frequency (SMD=0.61; 95% CI -0.25 to 1.47)
- No statistically significant effect on headache intensity (SMD=0.41; 95% CI -0.35 to 1.18)
- Only a moderate improvement in disability scores, but with very low to low certainty evidence 2
Special Considerations for Hemiplegic Migraine
Hemiplegic migraine presents unique challenges that make neck exercises even less appropriate:
- Triptans are contraindicated in hemiplegic migraine due to stroke risk 3
- Motor aura symptoms can last up to several weeks, markedly impairing quality of life 3
- The pathophysiology involves genetic mutations causing neuronal hyperexcitability and cortical spreading depression—mechanisms unrelated to cervical musculoskeletal function 3
Recommended Approach Instead
For hemiplegic migraine prevention, prioritize CGRP-targeting monoclonal antibodies, which have emerging evidence of efficacy specifically for this condition 3. For episodic migraine more broadly, current guidelines recommend:
First-Line Options:
- CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab) - "strong for" recommendation with demonstrated reductions in monthly migraine days 4
- Beta-blockers (propranolol, metoprolol) 5
- Antiseizure medications (topiramate, valproate) - "weak for" recommendation with clinically significant reductions in monthly migraine days 4
Key Pitfall to Avoid:
Do not delay effective pharmacologic prevention by attempting neck-strengthening programs first. While some patients may experience modest improvements in neck disability 2, this does not translate to meaningful migraine prevention and wastes valuable time during which the patient continues to suffer preventable attacks.
The evidence is clear: neck-strengthening programs lack efficacy for migraine prevention and should not be recommended, particularly for a patient with hemiplegic migraine who requires specialized pharmacologic management.